Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engerix-B Kinder challenge dose in adolescents primed with Infanrix hexa during infancy
2015-003391-74Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by GSK. Primary endpoint: Anti-HBs antibody concentrations. Started Feb 2016; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2015-003391-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003391-74.